002365
vs
S
Shanghai Composite
002365
Over the past 12 months, Qianjiang Yongan Pharmaceutical Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +75% compared to the Shanghai Composite's +23% growth.
Stocks Performance
002365 vs Shanghai Composite
Performance Gap
002365 vs Shanghai Composite
Performance By Year
002365 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Qianjiang Yongan Pharmaceutical Co Ltd
Glance View
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in the research, development, production and sales of taurine products. The company is headquartered in Qianjiang, Hubei and currently employs 927 full-time employees. The company went IPO on 2010-03-05. The firm operates through three main segments. The Taurine Products segment is mainly engaged in the research, development, manufacture and sales of taurine products, as well as the manufacture and sales of ethylene oxide. The Food Supplement segment is mainly involved in the research, development, manufacture and sales of dietary supplement, as well as the import and sales of overseas dietary supplement. The Health Field segment is mainly involved in the equity or industrial investment in health-related field.
